Pediatric Department, Hotat Beni Tamim General Hospital, Saudi Arabia
Background: Benign acute childhood myositis BACM is a self limited sudden onset of lower extremity pain and refusing to walk which considered a highly concerning sign to the parents. The primary complaint of pain in the calves in child presenting with a history of recent viral illness should bring BACM to the fore front of clinicians minds. Abrupt onset of severe lower leg pain occurs at a median of 3 days as the initial viral illness resolves.
Objective: In our study we want to explore that the treatment of BACM with IVIG (Intravenous immunoglobulin) will leads to decrease the estimated length of hospital stay to less than 2 day with a rapid recovery of walking difficulty without complications and with a high parental satisfaction among children presented with inability to walk in HBTGH.
Methods: We conducted a retrospective study on all the children admitted at Hotat Beni Tamim General Hospital at Saudi Arabia with the diagnosis of BACM and treated with IVIG (0.5 G/KG). In the last 5 years (from January 2019 to March 2024), the medical records of children diagnosed with BACM admitted were reviewed retrospectively. The following variables were retrieved from their electronic files: age, sex, prodromal symptoms, presenting symptoms, initial CPK level, follow up CPK level, total leukocytic count, length of stay, management with IVIG.
Results: Increased CPK level in (100%) ranging from 605 to 6410 U/L the median value of CPK at the peak was 1149 UI/L with a follow up decrease with median number 159 UI/L (normal CPK level < 150 UI/L). The p-value was 0.0001297 indicate that there is a significant difference between the CK-level and follow-up CK-level. Estimated length of stay was 1.9 days, in comparison with most literature 4 - 5 days. In our study all patients were treated with IVIG 0.5 G/KG one dose 10 cases (59%) and 2 doses 7 cases (41%).
Conclusion: Our study over 5 years and from 17 cases diagnosed as BACM demonstrated that our demographic results is like other studies but what is exciting in our study that our management of these cases with one or two doses of IVIG associated with a dramatic improvement in the child symptoms and without complications which has a great impact on the child and family satisfaction. And also by decreasing estimated length of stay to less than two days that reflects on a decrease in hospital acquired infection, and the overall patient cost.
Keywords: Benign Acute Childhood Myositis BACM; Viral Illness; Prodromal Symptoms
Abdulnasser Ahmed Al Skheita., et al. "Impact of IVIG Treatment in Decreasing the Average Length of Stay in Patient with BACM (Benign Acute Childhood Myositis): A 5 Years Experience". EC Paediatrics 13.5 (2024): 01-06.
© 2024 Abdulnasser Ahmed Al Skheita., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Open Access by ECronicon is
licensed under a Creative Commons Attribution
4.0 International License
Based on a work at www.ecronicon.net